Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-BRAF antibody (350-449) (STJ117227) | Login | Anti-BRAF antibody (350-449) (STJ117227) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNA2 antibody (1-200) (STJ117230) | Login | Anti-CCNA2 antibody (1-200) (STJ117230) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD68 antibody (16-200) (STJ117231) | Login | Anti-CD68 antibody (16-200) (STJ117231) | ||||||||||||||||
|
||||||||||||||||||
Anti-CHD1 antibody (1501-1710) (STJ117232) | Login | Anti-CHD1 antibody (1501-1710) (STJ117232) | ||||||||||||||||
|
||||||||||||||||||
Anti-CHKA antibody (1-170) (STJ117234) | Login | Anti-CHKA antibody (1-170) (STJ117234) | ||||||||||||||||
|
||||||||||||||||||
Anti-LTB4R antibody (320-337) (STJ117236) | Login | Anti-LTB4R antibody (320-337) (STJ117236) | ||||||||||||||||
|
||||||||||||||||||
Anti-FUT3 antibody (1-100) (STJ117252) | Login | Anti-FUT3 antibody (1-100) (STJ117252) | ||||||||||||||||
|
||||||||||||||||||
Anti-LRP6 antibody (20-150) (STJ117264) | Login | Anti-LRP6 antibody (20-150) (STJ117264) | ||||||||||||||||
|
||||||||||||||||||
Anti-NDUFC2 antibody (1-100) (STJ117267) | Login | Anti-NDUFC2 antibody (1-100) (STJ117267) | ||||||||||||||||
|
||||||||||||||||||
Anti-NOS3 antibody (639-738) (STJ117269) | Login | Anti-NOS3 antibody (639-738) (STJ117269) | ||||||||||||||||
|
||||||||||||||||||
Anti-TAS2R38 antibody (150-250) (STJ117281) | Login | Anti-TAS2R38 antibody (150-250) (STJ117281) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTGFR antibody (50-150) (STJ117282) | Login | Anti-PTGFR antibody (50-150) (STJ117282) | ||||||||||||||||
|
||||||||||||||||||
Anti-SSTR2 antibody (270-369) (STJ117295) | Login | Anti-SSTR2 antibody (270-369) (STJ117295) | ||||||||||||||||
|
||||||||||||||||||
Anti-TGFB1 antibody (30-390) (STJ117297) | Login | Anti-TGFB1 antibody (30-390) (STJ117297) | ||||||||||||||||
|
||||||||||||||||||
Anti-TRAF3 antibody (1-100) (STJ117300) | Login | Anti-TRAF3 antibody (1-100) (STJ117300) | ||||||||||||||||
|
||||||||||||||||||
Anti-FZD4 antibody (37-222) (STJ117307) | Login | Anti-FZD4 antibody (37-222) (STJ117307) | ||||||||||||||||
|
||||||||||||||||||
Anti-DGKD antibody (960-1140) (STJ117309) | Login | Anti-DGKD antibody (960-1140) (STJ117309) | ||||||||||||||||
|
||||||||||||||||||
Anti-RASAL2 antibody (750-1040) (STJ117314) | Login | Anti-RASAL2 antibody (750-1040) (STJ117314) | ||||||||||||||||
|
||||||||||||||||||
Anti-SPON1 antibody (29-300) (STJ117324) | Login | Anti-SPON1 antibody (29-300) (STJ117324) | ||||||||||||||||
|
||||||||||||||||||
Anti-CNTRL antibody (250-500) (STJ117332) | Login | Anti-CNTRL antibody (250-500) (STJ117332) | ||||||||||||||||
|
||||||||||||||||||
Anti-NCAPH antibody (1-250) (STJ117335) | Login | Anti-NCAPH antibody (1-250) (STJ117335) | ||||||||||||||||
|
||||||||||||||||||
Anti-TRAM1 antibody (305-374) (STJ117336) | Login | Anti-TRAM1 antibody (305-374) (STJ117336) | ||||||||||||||||
|
||||||||||||||||||
Anti-HEY2 antibody (17-32) (STJ117337) | Login | Anti-HEY2 antibody (17-32) (STJ117337) | ||||||||||||||||
|
||||||||||||||||||
Anti-KLHDC2 antibody (306-406) (STJ117340) | Login | Anti-KLHDC2 antibody (306-406) (STJ117340) | ||||||||||||||||
|
||||||||||||||||||
Anti-KLHDC2 antibody (306-406) (STJ117341) | Login | Anti-KLHDC2 antibody (306-406) (STJ117341) | ||||||||||||||||
|